Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
1.280
+0.342 (36.46%)
At close: Dec 20, 2024, 4:00 PM
1.240
-0.040 (-3.13%)
After-hours: Dec 20, 2024, 7:59 PM EST

Xilio Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Cash & Equivalents
61.2644.7120.39198.0519.2448.85
Cash & Short-Term Investments
61.2644.7120.39198.0519.2448.85
Cash Growth
2.49%-62.87%-39.22%929.49%-60.61%-
Prepaid Expenses
2.053.424.114.461.351.25
Other Current Assets
-----1.01
Total Current Assets
63.3148.13124.5202.5220.5951.1
Property, Plant & Equipment
9.5711.213.0613.914.069.87
Other Long-Term Assets
1.781.61.611.641.661.75
Total Assets
74.6660.93139.17218.0636.3262.72
Accounts Payable
0.971.053.133.145.442.52
Accrued Expenses
9.7910.510.338.7513.732.69
Current Portion of Long-Term Debt
-3.326.67-2.33-
Current Portion of Leases
1.151.110.880.65-
Total Current Liabilities
38.0215.9621.1212.7822.165.21
Long-Term Debt
--3.179.637.819.97
Long-Term Leases
7.268.149.2310.2311.19.02
Other Long-Term Liabilities
----0.54-
Total Liabilities
53.6824.133.5232.6341.624.2
Common Stock
0000--
Additional Paid-In Capital
391.63362.34354.75346.311.80.34
Retained Earnings
-370.66-325.51-249.11-160.89-85.09-29.87
Total Common Equity
20.9736.83105.65185.43-83.29-29.52
Shareholders' Equity
20.9736.83105.65185.43-5.2938.53
Total Liabilities & Equity
74.6660.93139.17218.0636.3262.72
Total Debt
8.4212.5520.0720.7421.8918.99
Net Cash (Debt)
52.8432.15100.32177.32-2.6529.86
Net Cash Growth
16.61%-67.95%-43.42%---
Net Cash Per Share
1.201.173.6631.63-5.0672.95
Filing Date Shares Outstanding
43.9634.4727.4327.360.810.41
Total Common Shares Outstanding
43.9627.6127.4327.360.810.41
Working Capital
25.2932.17103.38189.74-1.5745.9
Book Value Per Share
0.481.333.856.78-103.39-72.13
Tangible Book Value
20.9736.83105.65185.43-83.29-29.52
Tangible Book Value Per Share
0.481.333.856.78-103.39-72.13
Machinery
6.786.686.454.673.641.44
Construction In Progress
--0.10.54-2.2
Leasehold Improvements
5.125.125.125.125.09-
Source: S&P Capital IQ. Standard template. Financial Sources.